These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26347207)

  • 21. External validation of three dimensional conformal radiotherapy based NTCP models for patient-rated xerostomia and sticky saliva among patients treated with intensity modulated radiotherapy.
    Beetz I; Schilstra C; van Luijk P; Christianen ME; Doornaert P; Bijl HP; Chouvalova O; van den Heuvel ER; Steenbakkers RJ; Langendijk JA
    Radiother Oncol; 2012 Oct; 105(1):94-100. PubMed ID: 22169766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of submandibular salivary gland transfer and intensity-modulated radiotherapy to reduce dryness of mouth (xerostomia) in patients with head and neck cancer.
    Scrimger RA; Seikaly H; Vos LJ; Harris J; O'Connell D; Ghosh S; Debenham B; Jha N
    Head Neck; 2018 Nov; 40(11):2353-2361. PubMed ID: 30175876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early prediction of radiotherapy-induced parotid shrinkage and toxicity based on CT radiomics and fuzzy classification.
    Pota M; Scalco E; Sanguineti G; Farneti A; Cattaneo GM; Rizzo G; Esposito M
    Artif Intell Med; 2017 Sep; 81():41-53. PubMed ID: 28325604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
    Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Phase I-II study in the use of acupuncture-like transcutaneous nerve stimulation in the treatment of radiation-induced xerostomia in head-and-neck cancer patients treated with radical radiotherapy.
    Wong RK; Jones GW; Sagar SM; Babjak AF; Whelan T
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):472-80. PubMed ID: 12957259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of pilocarpine hydrochloride to prevent xerostomia in a child treated with high dose radiotherapy for nasopharynx carcinoma.
    Deutsch M
    Oral Oncol; 1998 Sep; 34(5):381-2. PubMed ID: 9861344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salivary gland function in nasopharyngeal carcinoma before and late after intensity-modulated radiotherapy evaluated by dynamic diffusion-weighted MR imaging with gustatory stimulation.
    Shi D; Qian JJ; Fan GH; Shen JK; Tian Y; Xu L
    BMC Oral Health; 2019 Dec; 19(1):288. PubMed ID: 31864328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiotherapy-induced xerostomia: a randomised, double-blind, controlled trial of Visco-ease™ oral spray compared with placebo in patients with cancer of the head and neck.
    Paterson C; Thomson MC; Caldwell B; Young R; McLean A; Porteous S; Clark S; Messow CM; Kean S; Grose D; Lamb C; Rizwannullah M; James A; Schipani S; Wilson C; Rulach R; Jones R
    Br J Oral Maxillofac Surg; 2019 Dec; 57(10):1119-1125. PubMed ID: 31672256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes and xerostomia after postoperative radiotherapy for oral and oropharyngeal carcinoma.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
    Head Neck; 2014 Oct; 36(10):1467-73. PubMed ID: 23996878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of xerostomia following radiotherapy: does age matter?
    Momm F; Guttenberger R
    Support Care Cancer; 2002 Sep; 10(6):505-8. PubMed ID: 12362919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dynamic observation on the short-term change of xerostomia after intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma].
    Li Y; Zhao C
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 50(1):33-7. PubMed ID: 25764925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevention and treatment of radiotherapy - induced xerostomia.
    Eisbruch A; Rhodus N; Rosenthal D; Murphy B; Rasch C; Sonis S; Scarantino C; Brizel D
    Semin Radiat Oncol; 2003 Jul; 13(3):302-8. PubMed ID: 12903018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effectiveness of thyme honey for the management of treatment-induced xerostomia in head and neck cancer patients: A feasibility randomized control trial.
    Charalambous A; Lambrinou E; Katodritis N; Vomvas D; Raftopoulos V; Georgiou M; Paikousis L; Charalambous M
    Eur J Oncol Nurs; 2017 Apr; 27():1-8. PubMed ID: 28279391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How should we measure and report radiotherapy-induced xerostomia?
    Eisbruch A; Rhodus N; Rosenthal D; Murphy B; Rasch C; Sonis S; Scarantino C; Brizel D
    Semin Radiat Oncol; 2003 Jul; 13(3):226-34. PubMed ID: 12903012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hermeneutic phenomenological interpretations of patients with head and neck neoplasm experiences living with radiation-induced xerostomia: the price to pay?
    Charalambous A
    Eur J Oncol Nurs; 2014 Oct; 18(5):512-20. PubMed ID: 24877858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term Use of the Sialogogue Medications Pilocarpine and Cevimeline Can Reduce Xerostomia Symptoms and Increase Salivary Flow in Head and Neck Cancer Survivors After Radiotherapy.
    Barbe AG
    J Evid Based Dent Pract; 2017 Sep; 17(3):268-270. PubMed ID: 28865825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy of Xialine in patients with xerostomia resulting from radiotherapy for head and neck cancer: a pilot-study.
    Jellema AP; Langendijk H; Bergenhenegouwen L; van der Reijden W; Leemans R; Smeele L; Slotman BJ
    Radiother Oncol; 2001 May; 59(2):157-60. PubMed ID: 11325444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiotherapy alone, versus radiotherapy with amifostine 3 times weekly, versus radiotherapy with amifostine 5 times weekly: A prospective randomized study in squamous cell head and neck cancer.
    Jellema AP; Slotman BJ; Muller MJ; Leemans CR; Smeele LE; Hoekman K; Aaronson NK; Langendijk JA
    Cancer; 2006 Aug; 107(3):544-53. PubMed ID: 16804929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of low-level laser therapy on radiotherapy-induced hyposalivation and xerostomia: a pilot study.
    Saleh J; Figueiredo MA; Cherubini K; Braga-Filho A; Salum FG
    Photomed Laser Surg; 2014 Oct; 32(10):546-52. PubMed ID: 25302460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of Wnt-1, TGF-β and related cell-cell adhesion components following radiotherapy in salivary glands of patients with manifested radiogenic xerostomia.
    Hakim SG; Ribbat J; Berndt A; Richter P; Kosmehl H; Benedek GA; Jacobsen HC; Trenkle T; Sieg P; Rades D
    Radiother Oncol; 2011 Oct; 101(1):93-9. PubMed ID: 21885141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.